Isofol Medical Ownership

Stocks . Sweden . 
Stock . Isofol Medical AB
ISOFOL Stock  SEK 1.05  0.04  3.96%   
Isofol Medical AB has a total of 161.52 Million outstanding shares. Isofol Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Isofol Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Isofol Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Isofol Medical AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Isofol Stock Ownership Analysis

About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Isofol Medical AB recorded a loss per share of 1.42. The entity had not issued any dividends in recent years. Isofol Medical AB , a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden. Isofol Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people. To learn more about Isofol Medical AB call Gustaf MSc at 46 3 17 97 22 80 or check out https://isofolmedical.com.

Isofol Medical Outstanding Bonds

Isofol Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Isofol Medical AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Isofol bonds can be classified according to their maturity, which is the date when Isofol Medical AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp Bond
US55336VAK61		View
MPLX LP 52 Corp Bond
US55336VAL45		View
BNP Paribas FRN Corp Bond
USF1R15XK367		View
Morgan Stanley 3591 Corp Bond
US61744YAK47		View
MGM Resorts International Corp Bond
US552953CD18		View
Valero Energy Partners Corp Bond
US91914JAA07		View

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Isofol Stock

Isofol Medical financial ratios help investors to determine whether Isofol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Isofol with respect to the benefits of owning Isofol Medical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY